Multidrug resistance proteins (MRPs): Structure, function and the overcoming of cancer multidrug resistance-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Multidrug resistance proteins (MRPs): Structure, function and the overcoming of cancer multidrug resistance

Published:2021-01 Issue: Volume:54 Page:100743
ISSN:1368-7646
Container-title:Drug Resistance Updates
language:en
Short-container-title:Drug Resistance Updates

Author:

Wang Jing-Quan,Yang Yuqi,Cai Chao-Yun,Teng Qiu-Xu,Cui Qingbin,Lin Jun,Assaraf Yehuda G.,Chen Zhe-Sheng

Funder

National Natural Science Foundation of China

Publisher

Elsevier BV

Subject

Pharmacology (medical),Infectious Diseases,Cancer Research,Pharmacology,Oncology

Reference244 articles.

1. In vivo evaluation of drug-drug interactions linked to UGT inhibition: the effect of probenecid on dalcetrapib pharmacokinetics;Aceves Baldo;Int. J. Clin. Pharmacol. Ther.,2013

2. Prolongation and enhancement of serum methotrexate concentrations by probenecid;Aherne;Br. Med. J.,1978

3. Multidrug resistance-associated protein 1 (MRP1) mediated vincristine resistance: effects of N-acetylcysteine and Buthionine sulfoximine;Akan;Cancer Cell Int.,2005

4. Sinusoidal efflux of taurocholate is enhanced in Mrp2-deficient rat liver;Akita;Pharm. Res.,2001

5. Identification of novel MRP3 inhibitors based on computational models and validation using an in vitro membrane vesicle assay;Ali;Eur. J. Pharm. Sci.,2017

Cited by 138 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Alteration in folate carrier expression via histone deacetylase inhibition in BeWo human placental choriocarcinoma cells;Toxicology in Vitro;2024-12

2. Phosphatidylserine-targeting bis(zinc-dipicolylamine) farnesol inhibits ATP production in cancer cells to overcome multidrug resistance;Supramolecular Materials;2024-12

3. Folylpolyglutamate synthetase inactivation in relapsed ALL induces a druggable folate metabolic vulnerability;Drug Resistance Updates;2024-11

4. Implications of nanotherapeutic advancements to leverage multi-drug resistant breast cancer: The state-of-the-art review;Journal of Drug Delivery Science and Technology;2024-10

5. Cancer Patient-Derived Cell-Based Models: Applications and Challenges in Functional Precision Medicine;Life;2024-09-10

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3